|
Question | Discussion | References | CME Credit
Case 2: References
- Husak R, Garbe C, Orfanos CE. Oral hairy leukoplakia in
71 HIV-seropositive patients: clinical symptoms, relation to immunologic
status, and prognostic significance. J Am Acad Dermatol. 1996;35:928-34.
[ PubMed
Abstract]
- Patton LL, McKaig R, Strauss R, Rogers
D, Eron JJ Jr. Changing prevalence of oral manifestations of human
immuno-deficiency virus in the era of protease inhibitor therapy. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:299-304.
[ PubMed
Abstract]
- Greenwood I, Zakrzewska JM, Robinson
PG. Changes in the prevalence of HIV-associated mucosal disease at
a dedicated clinic over 7 years. Oral Dis. 2002;8:90-4.
[ PubMed
Abstract]
- Katz MH, Greenspan D, Westenhouse
J, et al. Progression to AIDS in HIV-infected homosexual and bisexual
men with hairy leukoplakia and oral candidiasis. AIDS. 1992;6:95-100.
[ PubMed
Abstract]
- Centers for Disease Control and Prevention.
1993 revised classification system for HIV infection and expanded surveillance
case definition for AIDS among adolescents and adults. MMWR Recomm
Rep. 1992;41(RR-17):1-19. Available at:
[ Centers
for Disease Control and Prevention -
Accessed June 30, 2004]
- Mabruk MJ, Antonio M, Flint SR, et
al. A simple and rapid technique for the detection of Epstein-Barr
virus DNA in HIV-associated oral hairy leukoplakia biopsies. J Oral
Pathol Med. 2000;29:118-22.
[ PubMed
Abstract]
- Hille JJ, Webster-Cyriaque J, Palefski
JM, Raab-Traub N. Mechanisms of expression of HHV8, EBV and HPV in
selected HIV-associated oral lesions. Oral Dis. 2002;8 Suppl 2:161-8.
[ PubMed
Abstract]
- Kabani S, Greenspan D, deSouza Y,
Greenspan JS, Cataldo E. Oral hairy leukoplakia with extensive oral
mucosal involvement. Report of two cases. Oral Surg Oral Med Oral Pathol.
1989;67:411-5
[ PubMed
Abstract]
- Dias EP, Rocha ML, Silva JuniorA,
et al. Oral hairy leukoplakia. Histopathologic and cytopathologic features
of a subclinical phase. Am J Clin Pathol. 2000;114:395-401.
[ PubMed
Abstract]
- Triantos D, Porter SR, Scully C,
Teo CG. Oral hairy leukoplakia: clinicopathologic features, pathogenesis,
diagnosis, and clinical significance. Clin Infect Dis. 1997;25:1392-6.
[ PubMed
Abstract]
- Resnick L, Herbst JS, Ablashi DV,
Atherton S, Frank B, Rosen L, Horwitz SN. Regression of oral hairy
leukoplakia after orally administered acyclovir therapy. JAMA. 1988;259:384-8.
[ PubMed
Abstract]
- Pastore L, De Benedittis M, Petruzzi M, Fiore JR, Serpico R. Efficacy of famciclovir in the treatment of oral hairy leukoplakia. Br J Dermatol. 2006;154:378-9.
[ PubMed
Abstract]
- Walling DM, Flaitz CM, Nichols CM. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J Infect Dis. 2003;188:883-90.
[ PubMed
Abstract]
- Moura MD, GuimarĂ£es TR, Fonseca LM, de Almeida Pordeus I, Mesquita RA. A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:64-71.
[ PubMed
Abstract]
- Bhandarkar SS, MacKelfresh J, Fried L, Arbiser JL. Targeted therapy of oral hairy leukoplakia with gentian violet. J Am Acad Dermatol. 2008;58:711-2.
[ PubMed
Abstract]
[Back to Case 2 Question | Back
to Discussion]
CME
Credit | Back to Top
|